Macrophage MED1 deficiency aggravates atherosclerotic plaque vulnerability by impairing AMPK-dependent efferocytosis
Atherosclerosis
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Citation
Macrophage MED1 deficiency aggravates atherosclerotic plaque vulnerability by impairing AMPK-dependent efferocytosis. // Atherosclerosis. – URL: https://www.sciencedirect.com/science/article/pii/S0021915026013341?dgcid=rss_sd_all
Macrophage MED1 deficiency aggravates atherosclerotic plaque vulnerability by impairing AMPK-dependent efferocytosis. Atherosclerosis. https://www.sciencedirect.com/science/article/pii/S0021915026013341?dgcid=rss_sd_all
“Macrophage MED1 deficiency aggravates atherosclerotic plaque vulnerability by impairing AMPK-dependent efferocytosis.” Atherosclerosis.
@article{article106788,
title = {Macrophage MED1 deficiency aggravates atherosclerotic plaque vulnerability by impairing AMPK-dependent efferocytosis},
journal = {Atherosclerosis},
url = {https://www.sciencedirect.com/science/article/pii/S0021915026013341?dgcid=rss_sd_all}
}